Satellos Bioscience Inc. (MSLE) Free cash flow 2024–2025
Satellos Bioscience Inc. (MSLE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.6MFY2025 · since FY2024: -$18.3M → -$23.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.6M | -29.3% |
| FY2024 | -$18.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MSLE financial trends
MSLE RevenueMSLE Net incomeMSLE Net marginMSLE Gross profitMSLE Gross marginMSLE Operating incomeMSLE Operating marginMSLE Operating cash flowMSLE Capital expendituresMSLE Return on equityMSLE Stock buybacksMSLE Dividends paidMSLE Total assetsMSLE Total liabilitiesMSLE Shareholders’ equityMSLE overview →